Haisco Pharmaceutical Hits Day High with 8.65% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced significant activity today, achieving an intraday high of CNY 67.16, marking an 8.65% increase in its stock price. This performance stands in stark contrast to the China Shanghai Composite, which saw a modest gain of 0.5% on the same day. Over the past week, Haisco's stock has surged by 24.68%, and its one-month performance reflects a robust increase of 28.64%. Year-to-date, the stock has risen by 29.27%, significantly outperforming the broader market index. Notably, Haisco has delivered impressive returns over the past three years, with a staggering 181.1% increase, and a remarkable 314.11% rise over the last decade. The company has reported strong financial metrics, including a net profit growth of 1089.85% and an operating cash flow of CNY 1,126.55 million, the highest recorded. With a return on equity of 15.84% and a price-to-book ratio of 5.14, Haisco continues to demonstrate its position as a significant player in the pharmaceuticals and biotechnology sector.